Transurethralen Ablation der Prostata

Steam Treatment for Benign Prostatic Hyperplasia: Mayo Clinic Radio

Prostatitis und ätherische Öle

Der Urologe. MarchCite as. Ablative Laserverfahren zur Therapie der benignen Prostataobstruktion BPO gewinnen aufgrund transurethralen Ablation der Prostata geringerer Komplikationsraten als quasi ambulante Therapieformen an Bedeutung. Das mediane Transurethralen Ablation der Prostata beträgt 8 3—21 Monate. Das Alter lag bei 71 9— Jahren. Es gab nur eine substitutionsbedürftige Blutung. Langzeitergebnisse müssen die geringe Reoperationsrate bestätigen. Ablative laser methods for treating benign prostatic obstruction BPO have gained importance because of potentially lower complication rates than outpatient therapy methods.

Preoperative and postoperative prostate-specific antigen PSApeak urinary flow rate Q maxIPSS, prostate gland volume, and postvoid urine volume were prospectively measured. Median patient transurethralen Ablation der Prostata was 71 50—83 years, and mean operating time was There was only one case of significant bleeding. Short-term voiding complaints were expressed by The reoperation rate within 12 months was 6.

Postoperative voiding complaints are comparable to those with TURP. Long-term results are needed to confirm the low reoperation rate. Skip to main content. Advertisement Hide. Der Urologe MarchCite as. Authors Authors and affiliations M. Richter J. Schwarz P. Originalien First Online: 16 January Ziele Ablative Laserverfahren zur Therapie der benignen Prostataobstruktion BPO gewinnen aufgrund potenziell geringerer Komplikationsraten als quasi ambulante Therapieformen an Bedeutung.

Ergebnisse Das Alter lag bei 71 9— Jahren. Holmium laser ablation of the prostate An alternative to GreenLight photoselective vaporization of the prostate. Introduction Ablative laser methods for treating benign prostatic obstruction BPO have gained importance transurethralen Ablation der Prostata of potentially lower complication rates than outpatient therapy methods. Results Median patient age was 71 50—83 years, and mean operating time was This is a preview of subscription content, log in to check access.

Interessenskonflikt Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht. Muschter R free beam and contact laser coagulation. Wilson LC, Gilling PJ From coagulation to enucleation the use of lasers in surgery for benign prostatic hyperplasia. Can J Urol 7 1 : — Google Scholar. Bagley D, Das A Endourologic ese of the holmium laser. Mottet N, Anidjar M, Bourdon O et al A randomized comparison of transurethral electroresection and holmium:YAG laser vaporization for symptomatic transurethralen Ablation der Prostata prostatic hyperplasia.

Diagnosis and treatment. Rockville, Maryland Agency for health care policy and research. A cooperative study of 13 participating institutions evaluating 3, patients. Kumars SM Rapid communication holmium laser ablation of large prostate glands an endourologic alternative to open prostatectomy.

J Endo Urol 21 6 : — Google Scholar. Lourenco T, Pickard R, Vale L et al Alternative approaches transurethralen Ablation der Prostata endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials.

Seki N, Naito S Holmium laser for benign prostatic hyperplasia. Richter 1 Email author J. Schwarz 2 P. Albers 3 1. Münden Deutschland 2. Klinik für Urologie Universitätsklinik Düsseldorf Deutschland. Personalised recommendations. Cite article How to cite? ENW EndNote. Buy options.